Themes Klinische studie

Advise Reassessment of the threshold values for the presence of free lentiviral and retroviral vector particles in clinical trials with ex vivo transduced cells

20.05.2025

CGM/250520-01

Advisory reports
Joint open letter COGEM and ZKBS on the ERA of new vaccine developments based on samRNAs and VRPs

14.05.2025

CGM/250514-01

Policy reports
Generic environmental risk assessment of gene therapies that use GM cells containing free lentiviral particles

07.05.2020

CGM/200507-01

Advisory reports
Generic environmental risk assessment of clinical trials with AAV vectors

11.02.2020

CGM/190905-01

Advisory reports
Research report Assessment of preclinical gene therapy studies worldwide

04.09.2015

CGM 2015-03

Research reports
Replication-competent non-human viruses for use in clinical gene therapy: an inventory study

12.01.2011

CGM 2010-10

Research reports